Publications:25
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsBobby Liaw, MD
Internal Medicine, Cancer (Oncology), Hematology-Oncology
No Patient Experience Ratings
Book an Appointment
About Me
Bobby Liaw, M.D. specializes in the care and management of patient's with genitourinary and sarcoma cancers. He serves as the Clinical Director of Genitourinary Oncology for the Mount Sinai Health System, as well as the Medical Director for the Blavatnik Family Chelsea Medical Center at Mount Sinai.
He received his undergraduate degree at Cornell University, medical education at SUNY Downstate College of Medicine, graduated internal medicine residency from Beth Israel Deaconess Medical Center and completed his hematology/oncology fellowship training at Mount Sinai.
In addition to providing multidisciplinary care in the fields of genitourinary and sarcoma cancers, he is actively involved in clinical research. His main academic interests are in the translational and clinical investigation of genitourinary malignancies, with particular interests in developing new biomarkers and treatment strategies for metastatic castration-resistant prostate cancer.
A close personal interest of his is to help bridge cultural gaps in order to improve quality and access to healthcare to the Asian American community.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
About Me
Bobby Liaw, M.D. specializes in the care and management of patient's with genitourinary and sarcoma cancers. He serves as the Clinical Director of Genitourinary Oncology for the Mount Sinai Health System, as well as the Medical Director for the Blavatnik Family Chelsea Medical Center at Mount Sinai.
He received his undergraduate degree at Cornell University, medical education at SUNY Downstate College of Medicine, graduated internal medicine residency from Beth Israel Deaconess Medical Center and completed his hematology/oncology fellowship training at Mount Sinai.
In addition to providing multidisciplinary care in the fields of genitourinary and sarcoma cancers, he is actively involved in clinical research. His main academic interests are in the translational and clinical investigation of genitourinary malignancies, with particular interests in developing new biomarkers and treatment strategies for metastatic castration-resistant prostate cancer.
A close personal interest of his is to help bridge cultural gaps in order to improve quality and access to healthcare to the Asian American community.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Clinical Focus
- Adrenal Gland Tumors
- Bladder Cancer
- Genitourinary Malignancies
- Kidney Cancer
- Prostate Cancer
- Renal Cancer
- Sarcomas
- Sarcomas, Soft-Tissue
- Testicular Tumors
Video
Education
MD, SUNY Downstate Health Sciences University - College of Medicine
Internship, Internal Medicine
Beth Israel Deaconess Medical Center
Residency, Internal Medicine
Beth Israel Deaconess Medical Center
Residency, Hematology
Mount Sinai Hospital
Fellowship, Hematology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Research
Anti-Tumor Therapy, Cancer, Drug Resistance, Prostate
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- The Blavatnik Family – Chelsea Medical Center325 West 15th Street, 1st Floor, (between 8th and 9th Avenues), New York, NY, 10011
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Zakaria Chakrani, Mann Patel, George Mellgard, Stephen McCroskery, Nathaniel Saffran, Nicole Taylor, Bobby C. Liaw, Matthew Galsky, William Oh, Che Kai Tsao, Teja Ganta, Vaibhav Patel. Clinical Genitourinary Cancer
- Performance Status and End-of-Life Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Androgen Receptor Targeted Therapy. George Mellgard, Nathaniel Saffran, Zakaria Chakrani, Stephen McCroskery, Nicole Taylor, Mann Patel, Bobby Liaw, Matthew Galsky, William Oh, Che Kai Tsao, Vaibhav Patel. American Journal of Clinical Oncology: Cancer Clinical Trials
- Risk Factors for Early Treatment Discontinuation Due to Toxicity among Patients with Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy. Zakaria Chakrani, George Mellgard, Nathaniel Saffran, Stephen McCroskery, Nicole Taylor, Mann Patel, Bobby Liaw, Matthew Galsky, William K. Oh, Che Kai Tsao, Vaibhav G. Patel. American Journal of Clinical Oncology: Cancer Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Liaw during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Johnson & Johnson
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Liaw during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Johnson & Johnson
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.